Valter Gattei

15PUBLICATIONS
99CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesImmunogenetics (incl. genetic immunology)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 14, 2025
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Alberto J Arribas, Francesca Guidetti, Eleonora Cannas

|Jul 08, 2025
Integration of [<sup>18</sup>F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma.

Riccardo Dondolin, Federico Garrou, Mohammad Almasri

|Jun 18, 2025
Measurement of Immunoglobulin Intraclonal diversification refines the clinical impact of IGHV mutational status in chronic lymphocytic leukemia.

Filippo Vit, Tamara Bittolo, Antonella Zucchetto

|Dec 17, 2024
Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement.

Jana Nabki, Bashar Al Deeban, Abel Mehari Sium

|Aug 14, 2024
The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands.

Erika Tissino, Annalisa Gaglio, Antonella Nicolò

|Jun 26, 2024
Low Cell Bioenergetic Metabolism Characterizes Chronic Lymphocytic Leukemia Patients with Unfavorable Genetic Factors and with a Better Response to BTK Inhibition.

Simone Mirabilii, Monica Piedimonte, Esmeralda Conte

Pageof 3

Frequent Collaborators

9 joint publications

Riccardo Bomben

7 joint publications

Francesca Maria Rossi

5 joint publications

Jerry Polesel

4 joint publications

Riccardo Moia